Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164398 · ClinicalTrials.gov registry record · Phase 2
HIP: HIV Intervention for Providers
A Phase 2 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00164398 is a Phase 2 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 50 participants.
The verdict
NCT00164398, a Phase 2 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose is to encourage Provider participants to evaluate high risk HIV transmission behaviors and offer prevention messages to their HIV+ patients which will, in turn, reduce rates of unprotected anal and/or vaginal sex with partners of known HIV sero-negativity or unknown HIV serostatus. It is hypothesized that patients of providers participating in the HIP intervention will report higher reduction in sexual risk practices, when compared to the patients of the providers who were randomized into the control condition.
Interventions
- BEHAVIORAL HIP: HIV Intervention for Providers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2004-06 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00164398
The ClinicalTrials.gov registry entry for NCT00164398 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HIP: HIV Intervention for Providers is the first listed.
NCT00164398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00164398 about?
NCT00164398 is a clinical study titled "HIP: HIV Intervention for Providers". The purpose is to encourage Provider participants to evaluate high risk HIV transmission behaviors and offer prevention messages to their HIV+ patients which will, in turn, reduce rates of unprotected anal and/or vaginal sex with partners of known HIV sero-negativity or unknown HIV serostatus. It is...
What is the current status of trial NCT00164398?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2004-06. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00164398?
The interventions under investigation include: HIP: HIV Intervention for Providers (BEHAVIORAL).
Who is sponsoring clinical trial NCT00164398?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.